1-1420293-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001145210.3(ANKRD65):c.509C>T(p.Ala170Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000287 in 1,044,864 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001145210.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ANKRD65 | NM_001145210.3 | c.509C>T | p.Ala170Val | missense_variant | 3/4 | ENST00000537107.6 | |
ANKRD65-AS1 | XR_946814.2 | n.128G>A | non_coding_transcript_exon_variant | 1/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ANKRD65 | ENST00000537107.6 | c.509C>T | p.Ala170Val | missense_variant | 3/4 | 5 | NM_001145210.3 | P1 | |
ANKRD65-AS1 | ENST00000428932.1 | n.49G>A | non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000679 AC: 1AN: 147308Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000223 AC: 2AN: 897556Hom.: 0 Cov.: 30 AF XY: 0.00000237 AC XY: 1AN XY: 421832
GnomAD4 genome AF: 0.00000679 AC: 1AN: 147308Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 71672
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 08, 2023 | The c.509C>T (p.A170V) alteration is located in exon 3 (coding exon 2) of the ANKRD65 gene. This alteration results from a C to T substitution at nucleotide position 509, causing the alanine (A) at amino acid position 170 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at